UHR-OCT and HD-OCT for Preretinal Membranes: ICG Versus Membrane Blue
NCT ID: NCT00437593
Last Updated: 2008-09-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2005-09-30
2008-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Choroidal Thickness Vitrectomy
NCT02617147
Intraretinal Cystoid Changes After Vitrectomy With Membrane Peeling
NCT04472039
Brillant Blue Versus Indocyanine Green for Macular Hole Surgery
NCT00757471
"Cataract Surgery in Eyes With Epiretinal Membrane"
NCT03404323
Optical Coherence Tomography Angiography (OCTA) Changes in Patients With Epiretinal Membranes (ERM) With and Without Peeling of the Internal Limiting Membrane (ILM)
NCT05287009
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Main outcome measures are:
UHR-OCT, HD-OCT distance and near visual acuity and contrast sensitivity amsler grid secondary outcome measures are: OCT Stratus 3000 and visual field. Clinical examinations: preoperative, and follow-up examinations after 1 week, 1 months, 3 months, 6 months and 12 months.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ppVE, MP, ICG
surgery with ILM staining
ppVE, MP, MB
Surgery with ERM staining
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age between 18 and 85 years
* Combined surgery possible(phacoemulsification and vitreoretinal procedure)
Exclusion Criteria
* Previous retinal detachment surgery
* Previous laser treatment
18 Years
85 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Susanne Binder, MD
Role: STUDY_CHAIR
Ludwig Boltzmann Institue for Retinology and Biomicroscopic Lasersurgery
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Rudolf Foundation Clinic
Vienna, Vienna, Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FR-2-CI-2007
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.